Search results
Results from the WOW.Com Content Network
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
The Opioid and Drug Abuse Commission was a commission that advised the Trump administration on combating the ongoing opioid epidemic claiming more than 30,000 American fatalities annually in the United States. [2] The commission was chaired by New Jersey Governor Chris Christie. [3] The commission disbanded in December 2017.
The U.S. Drug Enforcement Administration is allowing one of the nation’s largest wholesale drug distributors to stay in business, reversing an earlier order stripping the company of its licenses ...
Horowitz's office also learned that the DEA Task Force Group selected the passenger based on information from a confidential DEA source, who was an employee of a commercial airline.
The drug policies put into place are enforced by the Food and Drug Administration and the Drug Enforcement Administration. Classification of Drugs are defined and enforced using the Controlled Substance Act, which lists different drugs into their respective substances based on its potential of abuse and potential for medical use. Four different ...
Maltz, a 28-year veteran of the DEA, said the agency is positioned to lead the nation’s drug enforcement and intelligence efforts by working closely with federal, state and local partners "to ...
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.